GT Medical Technologies Raises $16M To Expand Brain Tumor Therapy
Executive Summary
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
You may also be interested in...
New Data Confirm Safety Of GT Medical’s GammaTile Therapy For Brain Tumors
GT Medical is touting results from a validation study showing its GammaTile therapy controls the regrowth of brain tumors with a low rate of adverse events.
Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the final day of the meeting.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: